Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

29 August 2008

p53 codon 72 polymorphism and HPV status in lung cancer

Nur BuyruADEFG, Julide AltinisikBC, Mustafa IsinBC, Nejat DalayAEF

Med Sci Monit 2008; 14(9): CR493-497 :: ID: 867968


Several risk factors, both environmental and genetic, have been associated with the pathogenesis of lung cancer. A common polymorphism at codon 72 of exon 4 of the p53 gene encoding either an arginine or proline has been shown to confer susceptibility to the development of different human malignancies. This polymorphism affects proteolytic degradation of p53 promoted by the HPV-E6 protein and represents a risk factor for human-papillomavirus-induced carcinogenesis.
Material and Method
A total of 65 patients with lung cancer were recruited into the study and 87 healthy subjects were used as the control group. The codon 72 polymorphism was determined by the PCR-RFLP method. Presence of human papillomavirus DNA was analyzed by polymerase chain reaction using MY09 and MY11 consensus primers and hybridization with HPV16 and HPV18 specific probes.
The frequencies of the Arg and Pro alleles were 68.46% and 31.54% in lung cancer patients and 55.7% and 44.3% in the healthy control subjects, respectively. These differences were statistically significant. Human papillomavirus DNA was detected in the blood circulation of only 1 patient.
Our results suggest that the Arg/Arg genotype may represent a potential risk factor for the development of lung cancer independent of the HPV infection.

Keywords: Polymorphism, Genetic, Repressor Proteins - genetics, Papillomavirus Infections - pathology, Oncogene Proteins, Viral - genetics, Lung Neoplasms - virology, Genotype, Genetic Predisposition to Disease, Gene Frequency, Tumor Suppressor Protein p53 - genetics, DNA-Binding Proteins - genetics, DNA, Viral - blood, Codon - genetics, Aged, 80 and over

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Database Analysis  

Long-Term Prognosis of Patients Undergoing Percutaneous Coronary Intervention: The Impact of Serum Creatini...

Med Sci Monit In Press; DOI: 10.12659/MSM.943063  

Database Analysis  

Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...

Med Sci Monit In Press; DOI: 10.12659/MSM.943601  

Animal Research  

Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar Rats

Med Sci Monit In Press; DOI: 10.12659/MSM.942485  

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750